BTNX Rapid Response COVID-19 Antigen Test - Health Canada Approved
The Rapid Response™ COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions.
In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test.
Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but other diagnostic information is necessary to determine infection status.
Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.
The Rapid Response COVID-19 Antigen Rapid Test Device, manufactured by BTNX Inc., is a Health Canada authorized COVID-19 testing device.
Accessible, large-scale testing helps contain the virus spread. It is the perfect screening tool for organizations that want to protect their workplace from the risk of COVID-19 transmission.
Test time: 15 minutes
Test Technology: Antigen
Diagnostic Sensitivity: 78.6% - 96.2%
Diagnostic Specificity: 96.5%-100%
Quantity: 25 tests/kit
Sample Collection: Shallow nasal
- Easily deployed at a large scale
- Can be used in a wide variety of non-laboratory settings
- No special/additional instruments required
- Self-contained tube with "break off" swab minimizes staff exposure
- Extraction tube is fully enclosed for disposal
- 25 solutions per box (one for each test make it easy to share the box)
Disclaimer - Read Before Checkout
In Ontario, Alberta and British Columbia, the current guidance is that properly trained individuals may perform self-swabbing. Before Rapid Testing kits can be purchased, the following training materials and documents must be reviewed:
It is your responsibility to ensure that you have the appropriate knowledge, skills and judgement to perform the test.
Rapid antigen testing devices should only be used for screening purposes. Nucleic acid-based testing, also called molecular testing or PCR, is the gold standard to diagnose active COVID-19 infection in patients with symptoms. For more information about self-testing and antigen testing devices, please visit the Health Canada website here.
Information, regulations, and guidance around the use of rapid antigen testing devices in Canada is frequently changing. While The Safe Direct website is updated often, we recommend referring to the Health Canada website for the most up to date information on: